Prediction models for the histology of residual masses after chemotherapy for metastatic testicular cancer

International Journal of Cancer

Volumn 83, Issue 6, 1999, Pages 856-859

  Steyerberg, Ewout W ^a,c   Keizer, H Jan ^b   Habbema, J Dik F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SIZE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TESTIS CANCER;

GERMINOMA; HUMANS; LYMPH NODE EXCISION; MALE; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TERATOMA; TESTICULAR NEOPLASMS;

EID: 0032727677     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991210)83:6<856::AID-IJC31>3.0.CO;2-L     Document Type: Conference Paper

References (24)

1. BOSL, G.J. and MOTZER, R.J., Testicular germ-cell cancer. N. Engl. J. Med., 337, 242-253 (1997).
2. BREIMAN, L., Classification and regression trees, Wadsworth, Belmont, CA (1984).
3. CREMERIUS, U., EFFERT, P.J., ADAM, G., SABRI, O., ZIMMY, M., WAGENKNECHT, G., JAKSE, G. and BUELL, U., FDG PET for detection and therapy control of metastatic germ cell tumor. J. nucl. Med., 39, 815-822 (1998).
4. DEBONO, D.J., HEILMAN, D.K., EINHORN, L.H. and DONOHUE, J.P., Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J. clin. Oncol., 15, 1455-1464 (1997).
5. DONOHUE, J.P., ROWLAND, R.G., KOPECKY, K., STEIDLE, C.P., GEIER, G., NEY, K.G., EINHORN, L., WILLIAMS, S. and LOEHRER, P., Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J. Urol., 137, 1176-1179 (1987).
6. EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet, 339, 1-15 (1992).
7. EINHORN, L.H., Treatment of testicular cancer: a new and improved model. J. clin. Oncol., 8, 1777-1781 (1990).
8. EINHORN, L.H., WILLIAMS, S.D., MANDELBAUM, I. and DONOHUE, J.P., Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer, 48, 904-908 (1981).
9. FOSSÅ, S.D., QVIST, H., STENWIG, A.E., LIEN, H.H., OUS, S. and GIERCKSKY, K.E., Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses? J. clin. Oncol., 10, 569-573 (1992).
10. Fox, E.P., WEATHERS, T.D., WILLIAMS, S.D., LOEHRER, P.J., ULBRIGHT, T.M., DONOHUE, J.P. and EINHORN, L.H., Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J. clin. Oncol., 11, 1294-1299 (1993).
11. GELDERMAN, W.A., KOOPS, H.S., SLEIJFER, D.T., OOSTERHUIS, J.W. and OLDHOFF, J., Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer, 58, 1418-1421 (1986).
12. INTERNATIONAL GERM CELL CANCER COLLABORATIVE GROUP. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. clin. Oncol., 15, 594-603 (1997).
13. JANSEN, R.L. AND 12 OTHERS FOR THE EORTC GU GROUP, Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. Eur. J. Cancer, 27, 695-698 (1991).
14. KNAUS, W.A., WAGNER, D.P., DRAPER, E.A., ZIMMERMAN, J.E., BERGNER, M., BASTOS, P.O., SIRIO, C.A., MURPHY, D.J., LOTRING, T., DAMIANO, A. and HARRELL, F.E., The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest, 100, 1619-1636 (1991).
15. KOLE, A.C., HOEKSTRA, H.J., SLEIJFER, D.T., NIEWEG, O.E., SCHRAFFORDT KOOPS, H. and VAALBURG, W., 1-[1-Carbon-11]tyrosine imaging of metastatic testicular nonseminoma germ-cell tumors. J. nucl. Med., 39, 1027-1029 (1998).
16. NUUTINEN, J.M., LESKINEN, S., ELOMAA, I., MINN, H., VARPULA, M., SOLIN, O., SODERSTROM, K.O., JOENSUU, H. and SALMINEN, E., Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Europ. J. Cancer, 33, 1234-1241 (1997).
17. SAGALOWSKY, A.I., EWALT, D.H., MOLBERG, K. and PETERS, P.C., Predictors of residual mass histology after chemotherapy for advanced testis cancer. Urology, 35, 537-542 (1990).
18. STEPHENS, A.W., GONIN, R., HUTCHINS, G.D. and EINHORN, L.H., Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J. clin. Oncol., 14, 1637-1641 (1996).
19. STEYERBERG, E.W., GERL, A., FOSSA, S.D., SLEUFER, D.T., DE WIT, R., KIRKELS, W.J., SCHMELLER, N., CLEMM, C., HABBEMA, J.D. and KEIZER, H.J., Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J. clin. Oncol., 16, 269-274 (1998).
20. STEYERBERG, E.W. AND 14 OTHERS, Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J. clin. Oncol., 13, 1177-1187 (1995).
21. STEYERBERG, E.W., KEIZER, H.J., STOTER, G. and HABBEMA, J.D., Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections. Europ. J. Cancer, 30A, 1231-1239 (1994).
22. STIELL, I.G., MCKNIGHT, R.D., GREENBERG, G.H., MCDOWELL, I., NAIR, R.C., WELLS, G.A., JOHNS, C. and WORTHINGTON, J.R., Implementation of the Ottawa ankle rules. J. amer. med. Assoc., 271, 827-832 (1994).
23. STOMPER, P.C., KALISH, L.A., GARNICK, M.B., RICHIE, J.P. and KANTOFF, P.W., CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology, 180, 711-714 (1991).
24. TONER, G.C. AND 16 OTHERS, Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J. clin. Oncol., 8, 1683-1694 (1990).